Patients with ADHD will wear InnoSphere’s electrode-embedded cap for 20 minutes over the course of 15 days. Photo
An Israeli startup has developed a new medical device to treat attention deficit hyperactivity disorder (ADHD). And it doesn’t require any drugs like Ritalin or Adderall.
Haifa-based InnoSphere’s patented medical “cap” sits on top of the patient’s head. Small electrodes embedded in the cap deliver electrical charges to regions of the brain that are involved in ADHD behavior. The cap is worn for 20 minutes a day, for 15 days only.
InnoSphere’s goal is to stimulate the neurons in the brain to make new connections in areas where those suffering from ADHD are deficient.
“We give the neurons a nudge to talk to other neurons in the brain, to communicate better,” founder and CEO Rami Shacour tells ISRAEL21c.
InnoSphere’s ADHD device takes advantage of “neuroplasticity” – the brain’s ability to reorganize itself by forming new neural connections in response to novel activities and situations or to compensate for injury or disease.
That makes it different than other Israeli-made neuromodulation devices ISRAEL21c has covered, such as Neurolief or Theranica, both of which aim to eliminate the pain of migraine headaches by electrically stimulating specific nerves.
InnoSphere’s product will be prescribed by a doctor after making an ADHD diagnosis and identifying the severity of the symptoms. The doctor will upload that information to InnoSphere’s online platform where, says Shacour, “our AI algorithms will generate a personal treatment protocol.”-- More...
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.
